主动脉与动脉脆弱谱:主动脉病与动脉病风险分层及精准手术决策的生物学概念框架
本文提出主动脉与动脉脆弱谱(AAVS)这一生物学概念框架,通过整合高可靠性系统理论、细胞外基质生物学和临床结局模式,将生物学风险分为基质脆弱性、临床脆弱性和失效机制三个域,并引入皮肤活检作为主动脉壁完整性的组织替代指标,提出正在开发中的评分系统,旨在改进主动脉病和动脉病的风险分层与手术决策。
要点
- AAVS框架将生物学风险分为基质脆弱性、临床脆弱性和失效机制三个域,各域对应正在开发的评分系统。
- 皮肤活检的组织学和透射电镜分析用于识别胶原和弹性蛋白组织的可分级超微结构特征,作为主动脉组织完整性的替代指标。
- 失效被重新定义为由基质完整性塑造的渐进性生物学过程,而不仅是解剖或手术成功。
核心结论
- AAVS提出了一个结构化的临床推理框架和基于皮肤活检的评分方法,用于主动脉病和动脉病的风险分层。
- 该框架将失效重新定义为由基质完整性塑造的渐进性生物学过程,而不仅是解剖或手术成功。
- 尽管评分系统仍在开发中,该认知框架对病例解读、生物学匹配的手术规划和未来纵向建模具有即时实用性。
- 正在进行的工作旨在验证评分系统并在多样化的临床队列中完善生物学风险评估。
研究设计与样本
- 该框架通过结构化的、假设驱动的过程开发,整合了高可靠性系统理论、细胞外基质生物学和临床结局模式。
- 引入皮肤活检作为主动脉壁完整性的组织水平替代指标的新应用。
- 使用组织学和透射电子显微镜分析来识别胶原和弹性蛋白组织的可分级超微结构特征。
- 通过临床病例图示展示概念实用性。
主要发现
- AAVS框架定义了三个生物学风险域:基质脆弱性、临床脆弱性和失效机制。
- 基质脆弱性通过皮肤活检的组织学和超微结构分析的AAVS评分评估,作为主动脉组织完整性的替代。
- 临床脆弱性由血管脆弱性评分捕获,该评分从临床病史、体格检查和影像学中量化血管脆弱性的表型指标。
- 失效机制由基质脆弱性进展建模,这是一个纵向动态建模系统,追踪基质脆弱性随时间向主动脉失效的进展,并包括改变不匹配进展的血管健康调节因素。
临床怎么用
- 该认知框架目前即可用于病例解读和生物学匹配的手术规划。
- 皮肤活检的组织学和超微结构分析可作为主动脉组织完整性的替代指标,用于评估基质脆弱性。
- 血管脆弱性评分可从临床病史、体格检查和影像学中量化血管脆弱性的表型指标。
- 基质脆弱性进展的纵向动态建模系统可追踪基质脆弱性随时间向主动脉失效的进展,并包括血管健康调节因素。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To introduce the Aortic and Arterial Vulnerability Spectrum (AAVS), a biologically grounded conceptual framework designed to improve risk stratification and surgical decision-making in aortopathy and arteriopathy by incorporating substrate-level insights. METHODS: The framework was developed using a structured, hypothesis-driven process that integrates high-reliability systems theory, extracellular matrix biology, and clinical outcome patterns. A novel application of skin biopsy is introduced as a tissue-level surrogate for aortic wall integrity. Histological and transmission electron microscopy analyses were used to identify gradable ultrastructural features of collagen and elastin organization. The AAVS framework defines three biological risk domains, substrate vulnerability, clinical fragility, and mechanisms of failure, each linked to a proposed scoring system under development. Clinical case illustrations demonstrate conceptual utility. RESULTS: The three domains of biological risk are (1) substrate vulnerability, assessed through the AAVS Score of histological; and ultrastructural analysis of skin biopsy as a surrogate for aortic tissue integrity; (2) clinical fragility, captured by the Vascular Fragility Score, which quantifies phenotypic indicators of vascular fragility from clinical history, physical findings, and imaging; and (3) mechanisms of failure, modeled by substrate vulnerability progression, a longitudinal, dynamic modeling system that tracks substrate vulnerability progression over time toward aortic failure and includes vascular health modifiers that alter mismatch progression over time. CONCLUSIONS: AAVS introduces a structured clinical reasoning framework and skin biopsy-based scoring approach for risk stratification in aortopathy and arteriopathy. It reframes failure as a progressive biological process shaped by substrate integrity, not just anatomy or procedural success. Although the scoring systems remain under development, the cognitive framework offers immediate utility for case interpretation, biologically matched surgical planning, and future longitudinal modeling. Ongoing work aims to validate the scoring systems and refine biological risk assessment across diverse clinical cohorts.
引用
- Shalhub S. The aortic and arterial vulnerability spectrum: A conceptual biological framework for risk stratification and precision surgical decision-making in aortopathy and arteriopathy. J Vasc Surg. 2025. PMID: 40471774. doi:10.1016/j.jvs.2025.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。